ArticleACS omega2026
Electronic Detection of Functional Cellular Immunity Using Enzymatic Metallization.
Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Microparticle-enabled single cell multiparameter electronic immunophenotyping for selective electroporation.Lab on a chip · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Accurate detection of immune cell function at the single-cell level is needed for diagnostic and research applications, yet conventional methods such as flow cytometry require complex instrumentation and fluorescent labeling which limits their use in resource-poor settings. To address this limitation, we developed Electronic Phenotyping using Impedance Cytometry (EPIC), a platform that combines antibody-directed enzymatic metallization on the cell surface with multifrequency impedance analysis, in a microscale 3D-printed plastic aperture, to electronically detect surface marker-based metallization and cytokine secretion. Using CD45-targeted metallization, EPIC generated distinct impedance signatures in Jurkat cells and primary human peripheral blood mononuclear cells, with impedance changes correlating to surface metallization. A bispecific capture strategy coupled to the metallization was then used for detection of IFN-γ secretion of cells, with impedance readouts matching flow cytometry. These findings demonstrate the ability of the EPIC system for sensitive electronic immune profiling and support its potential as a scalable, low-cost alternative to fluorescence-based assays for point-of-care cellular immunity based diagnostics.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.